$AKTX If Nomacopan is found to be effective or not for treating COVID-19 related diseases, this is really a win win situation for Akari. First, its being paid by another sponsor. Second, think of the amount of data they will get. Third, the fact that it is being tested on more humans could lead other potential compassionate use indications in the future.
  • 10